# INVO Fertility, Inc. (IVF)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $167,428.69  
**Price:** $1.43 (+1.42%)

> INVO Fertility, Inc. is a healthcare services company focused on the fertility market, providing assisted reproductive technology care through innovative clinic operations and medical devices. It operates fertility clinics, including branded INVO Centers dedicated primarily to the intravaginal culture procedure enabled by its proprietary INVOcell device, as well as traditional in vitro fertilization clinics. The INVOcell is a medical device that facilitates fertilization and early embryo development in vivo within the woman's body, offering an alternative to conventional lab-based methods. The company also sells and distributes the INVOcell device to third-party fertility clinics. Its services encompass a range of reproductive options such as IVF, intravaginal culture, intrauterine insemination, fertility preservation, and advanced diagnostic testing. INVO Fertility, Inc. maintains a network of operational clinics in the United States and pursues acquisitions to expand its platform. Founded in 2007 and headquartered in Sarasota, Florida, it plays a role in making fertility treatments more accessible in the healthcare sector.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $7M | $7M | -$7M | -$23M | — |
| 2024 | $7M | $3M | -$7M | -$9M | — |
| 2023 | $3M | $1M | -$7M | -$8M | — |
| 2022 | $822,196 | $490,673 | -$11M | -$11M | — |
| 2021 | $4M | $4M | -$5M | -$7M | — |
| 2020 | $1M | $948,526 | -$6M | -$8M | — |
| 2019 | $1M | $1M | -$2M | -$2M | — |
| 2018 | $494,375 | $404,008 | -$3M | -$3M | — |
| 2017 | $282,145 | $230,191 | -$640,421 | -$702,163 | — |
| 2016 | $50,901 | $35,807 | -$2M | -$2M | — |
| 2015 | $11,689 | $3,879 | -$595,074 | -$5M | — |
| 2014 | $16,588 | $8,906 | -$2M | -$2M | — |
| 2013 | $27,063 | $16,479 | -$605,233 | -$760,679 | — |
| 2012 | $56,377 | $35,497 | -$552,299 | -$666,454 | — |
| 2011 | $71,503 | $53,591 | -$703,126 | -$797,471 | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $20M | $13M | $7M | — | $892,488 |
| 2024 | $46M | $26M | $13M | — | $7M |
| 2023 | $19M | $18M | $892,825 | — | — |
| 2022 | $4M | $5M | -$977,612 | — | — |
| 2021 | $10M | $3M | $7M | $6M | — |
| 2020 | $11M | $5M | $6M | $10M | — |
| 2019 | $2M | $6M | -$4M | $1M | — |
| 2018 | $777,347 | $4M | -$3M | $212,243 | — |
| 2017 | $266,413 | $5M | -$5M | $25,759 | — |
| 2016 | $286,226 | $5M | -$5M | $152,404 | — |
| 2015 | $579,786 | $4M | -$4M | $492,004 | — |
| 2014 | $108,051 | $4M | -$4M | $18,626 | — |
| 2013 | $122,543 | $4M | -$4M | $18,027 | — |
| 2012 | $125,269 | $3M | -$3M | $7,194 | — |
| 2011 | $127,878 | $3M | -$3M | $403 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$7M | $43,412 | -$7M |
| 2024 | -$3M | $183,703 | -$3M |
| 2023 | -$5M | $444,722 | -$5M |
| 2022 | -$7M | $10,785 | -$7M |
| 2021 | -$6M | $415,710 | -$6M |
| 2020 | -$5M | $49,261 | -$5M |
| 2019 | $1M | $64,839 | $1M |
| 2018 | -$652,971 | $19,400 | -$672,371 |
| 2017 | -$181,270 | — | -$181,270 |
| 2016 | -$323,900 | $15,700 | -$339,600 |
| 2015 | -$151,622 | — | -$151,622 |
| 2014 | -$19,401 | — | — |
| 2013 | -$59,916 | — | — |
| 2012 | -$43,209 | — | — |
| 2011 | -$117,779 | — | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/IVF)